Jazz Pharmaceuticals (JAZZ) Reports In-Line Q4 EPS, FY Guidance Comes in Light
Go back to Jazz Pharmaceuticals (JAZZ) Reports In-Line Q4 EPS, FY Guidance Comes in Light| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 248.36 +3.40 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $244.96 | 52 Week High | $160.00 | |||
| Open | $244.00 | 52 Week Low | $95.80 | |||
| Day High | $248.52 | P/E | 46.16 | |||
| Day Low | $243.16 | EPS | $5.38 | |||
| Volume | 504,851 | |||||
